SION
Sionna Therapeutics, Inc.Company with tickers: SION
CIK
2036042
CUSIP
829401108
Shares Outstanding
45,150,330
Website
https://www.sionnatx.com
13F Activity (30d)
31 filings
31 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $29,599,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Research & Development | $18,963,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Income | $-29,599,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-26,779,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-0.60 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-0.60 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |